Posted by Michael Wonder on 23 Feb 2021
FDA approves EndoClot Hemostat to manage GI bleeding
23 February 2021 - A unique product to rapidly and reliably control bleeding during GI procedures.
EndoClot Plus announced the U.S. FDA has approved EndoClot Polysaccharide Hemostatic System (EndoClot PHS), an innovative product that assists gastro-enterologists to stop bleeding rapidly and reliably.
